Delivery Order SPE2DB22D1103-SPE2DB24FTGA3
Award Date 3/4/24
Potential Completion Date 3/25/24
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for INQOVI 35 MG-100 MG tablets in a quantity of 5 units under a firm fixed-price contract with a ceiling value of $5,119.36. This non-competitive delivery order was issued on June 17, 2025, with an ultimate completion date of July 10, 2025, and reflects AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement systems. AmerisourceBergen Drug Corp, headquartered in...
- This is a $5,119.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide INQOVI 35 MG-100 MG tablets. The contract has an ultimate completion date of June 20, 2025 and is not set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for supplying a wide...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564134395! INQOVI 35 MG-100 MG TABLET UU 5S. The award, valued at $4,830.47, has an ultimate completion date of April 22, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, specializes in supplying pharmaceuticals, medical supplies, and related distribution services to...
- The Defense Logistics Agency awarded a $5,119.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for INQOVI 35 mg-100 mg tablets in a 5-count unit pack on September 22, 2025, with completion scheduled for October 14, 2025. This non-competitive delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of INQOVI 35 MG-100 MG tablets. The $5,119.36 firm fixed-price contract has a period of performance through March 7, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency awarded a $10,238.74 delivery order to AmerisourceBergen Drug Corp for INQOVI 35 mg-100 mg tablets on September 22, 2025, with completion targeted for October 14, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $9,660.94, is for the delivery of the specialty medication INQOVI 35 MG-100 MG TABLET with a completion date of March 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $5,119.36 to AmerisourceBergen Drug Corp for INQOVI 35 mg-100 mg tablets on August 29, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, non-set-aside contract utilizing firm fixed pricing was issued under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order from the Defense Logistics Agency (DLA) valued at $5,119.36. The contract is for the supply of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has a period of performance through March 13, 2025 and is a Firm Fixed Price contract type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
- This is a $9,660.94 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for INQOVI 35 MG-100 MG tablets, a pharmaceutical product, with a completion date of January 30, 2024. The contract has no set-aside designation. AmerisourceBergen Drug Corp has received numerous federal contracts to supply pharmaceuticals, medical supplies, and distribution services...